Our Members Asked:
Do any supplements, foods or lifestyle modifications help with brain function, like memory and cognition?
There is preliminary evidence that certain supplements modestly improve various aspects of memory or cognition. These benefits include boosting memory in people who do not have memory problems as well as improving memory or cognition in people with age-related cognitive decline, Alzheimer’s disease, and other forms of dementia.
In addition, certain foods, diets, and lifestyle changes have been associated with improvements in cognition or a decreased risk of dementia.
See the information below, which includes links to more details about each supplement, including clinical evidence, dosage, and ConsumerLab's tests, reviews, and Top Picks for each type of supplement.
For Cognitively Healthy Adults & Adolescents
Bacopa (Bacopa monnieri) is an herb which several small trials suggest may have very modest benefits in healthy adults without memory or cognitive deficits.
Choline supplements may help improve short-term memory and attention in healthy older adults, but this benefit has only been found with certain forms of choline. Choline supplements do not appear to be beneficial in younger individuals.
Coffee or coffee extracts are common ingredients in memory supplements sold in the U.S., but no clinical studies have evaluated long-term use of coffee or coffee extracts for memory. A study in mice found that higher blood levels of caffeine, a constituent of coffee, was associated with a reduction of beta-amyloid plaques — accumulations of beta-amyloid protein pieces that have been linked with Alzheimer's disease. Other laboratory research has suggested that other compounds in coffee may affect memory by preventing the breakdown of acetylcholine (which is important for memory and learning) or reducing the impact of excess calcium on brain cells. However, these potential effects have not been confirmed in humans (Hersant, CNS Drugs 2023).
Curcumin (from turmeric) may modestly improve some aspects of memory and cognition in healthy adults, but the benefit appears to be limited to several hours after use. Curcumin does not appear to be beneficial among people with Alzheimer's disease (see below).
Fish oil and omega-3 fatty acid supplements may slightly improve certain measures of memory and cognition in healthy adults who do not regularly consume fish and those with very low blood levels of DHA, although not all studies have found a benefit. Supplementing with calanus oil, a source of omega-3 fatty acids, does not seem to improve memory.
Ginger might improve short-term memory in healthy women, but more research is needed to confirm.
Ginkgo biloba may have some slight, short-term cognitive benefit in healthy adults, but be aware that studies have generally been company-funded, and not all studies have found a benefit.
Iron supplementation to correct iron deficiency has been shown to improve verbal learning and memory in adolescent girls.
Ketones (also called ketone bodies) are molecules produced in the liver from fatty acids and can be used in the body and in the brain for energy when glucose (i.e., sugar) is not available. One small study found that a ketone-containing drink modestly increased cerebral blood flow and improved scores on one test of motor speed and visual attention in obese adults, but larger, long-term studies are needed to prove a benefit.
Lutein and zeaxanthin are carotenoids with antioxidant properties that are often included in vision health supplements, but there is preliminary evidence that these antioxidants may also improve brain functions such as visual processing, speed of processing, attention and memory, as well as reduce computer and screen-related headaches and eye strain.
Magnesium from foods and/or supplements may improve cognition in healthy older adults who consume much higher amounts of calcium than magnesium. Getting enough magnesium -- but not too much -- has also been associated with a decreased risk of developing mild cognitive impairment or dementia.
Regular, long-term supplementation with a multivitamin may slightly slow declines in memory in older adults, although the strongest benefit appears to be among those who also have cardiovascular disease.
No clinical evidence of a benefit:
Apoaequorin, a protein found in jellyfish, is promoted for memory based on its ability to bind to excess calcium. Excess calcium may damage brains cells and result in memory impairment. However, there do not appear to be any studies showing that apoaequorin reaches the brain when taken as a supplement, or that it binds to enough excess calcium to reduce the risk of brain cell damage. Apoaequorin is the main ingredient in Prevagen (Quincy Bioscience), a supplement marketed for improving memory and supporting clearer thinking, although these effects are not well substantiated by clinical research.
Beta-alanine supplementation does not appear to significantly improve cognitive function among healthy older adults.
Small studies have suggested that cocoa flavanols could be beneficial in people with normal cognition, but the largest and longest trial to date did not find a cognitive benefit of cocoa flavanols in cognitively healthy older adults.
Cranberry supplementation has been proposed to help with memory and cognition due to its potential anti-inflammatory and antioxidant effects, but a study among healthy older adults showed very little improvement.
A study among healthy young adults showed no significant benefit of grape seed extract for cognitive function.
Drinking green tea has been associated with a lower risk of cognitive decline in older adults, although a clinical trial in which people were given green tea (as a beverage) showed no or only very modest benefit for memory and cognition. Green tea extracts (such as in capsules) do not appear to improve cognition or memory in older people, although they may cause short-term improvement in attention (possibly due to caffeine).
Inositol-stabilized arginine silicate, also called arginine silicate inositol or ASI (available as the branded ingredient Nitrosigine), is considered to be a more bioavailable source of arginine which may help to improve blood flow. However, a study showed very little cognitive benefit in young adults who supplemented with ASI.
Supplementation with lion's mane does not appear to improve most measures of cognitive function among healthy older or younger adults.
Plasmalogen supplements may, at best, slightly improve memory in healthy adults with forgetfulness, but they don't seem to improve memory, attention, or cognitive function in other healthy adults.
Sulforaphane is a compound produced in the gut from glucoraphanin, an inactive constituent in broccoli and other cruciferous vegetables. There is speculation that sulforaphane may improve cognitive function based on its antioxidant and anti-inflammatory effects, but this does not appear to be supported by clinical evidence. A study among 144 healthy older adults (average age 67) showed that supplementing with 30 mg of glucoraphanin (about the amount in 2 cups of raw broccoli) once daily with water for 12 weeks did not improve most measures of cognition, including executive function or memory, compared to placebo. While processing speed was shown to improve based on one scale, it did not improve based on another scale. Interestingly, no significant changes in biomarkers of oxidative stress or inflammation were observed in this study. Analysis of urine samples showed increased levels of sulforaphane N-acetyl-L-cysteine, the main metabolite of sulforaphane, indicating that glucoraphanin was converted to (and increased levels of) sulforaphane (Nouchi, Front Aging Neurosci 2022).
Vitamin E supplementation doesn't seem to improve memory or cognition in healthy older men with normal cognitive function, but high-dose vitamin E may modestly help people with Alzheimer's disease (see below).
For Age-related Cognitive Decline
Age-related cognitive decline is not considered a disease but a more gradual and, perhaps, normal consequence of aging. Below are supplements that may have modest benefit in older adults or in people with age-related cognitive decline.
Fish oil supplements may modestly improve some measures of cognition in adults with age-related cognitive decline, but the evidence is mixed and may depend on the level of cognitive function prior to treatment, age, diabetes status, and whether or not fish is already being consuming fish in the diet.
Phosphatidylserine derived from cow brain tissue showed benefit for Alzheimer's disease and other forms of age-related cognitive decline in the 1980s and 90s. However, this form is now rarely sold, and plant-derived phosphatidylserine has shown modest evidence of benefit, at best, for age-related memory impairment. Nevertheless, a modified form of soy-derived phosphatidylserine has shown some benefit.
Spermidine is a naturally occurring compound produced in our bodies and found in a variety of foods. It plays an important role in cell maintenance and the clearance of damaged or abnormal cells and may also have anti-inflammatory effects. Although higher dietary intakes of spermidine have been associated with lower incidence of cognitive impairment in people (Schroeder, Cell Rep 2021), spermidine supplementation has generally not shown benefit. A possible explanation for the lack of benefit is that the dosages used in studies have been low (0.9 to 1.2 mg per day) (Nowotarski, Expert Rev Mol Med 2013), and even a somewhat higher dose was not shown to raise blood levels of spermidine, and only slightly increased in blood levels of spermine (a metabolite spermidine) compared to placebo (Senekowitsch, Nutrients 2023). The use of low doses in studies has been driven, in part, due to concerns from animal and laboratory studies, that compounds like spermidine (polyamines) may promote tumor growth in cancers such as breast, colon, lung, prostate and skin cancer (Nowotarski, Expert Rev Mol Med 2013), and even in one of the low-dose studies, a greater number of participants who took spermidine reported musculoskeletal and connective tissue adverse effects during the course of the study compared to those taking the placebo (11 participants vs 4 in the placebo group), although the difference was not statistically significant (Schwarz, JAMA Netw Open 2022).
For Mild Cognitive Impairment (MCI)
Acetyl-L-carnitine supplementation may have some benefit in people with mild cognitive impairment.
Ashwagandha may improve immediate and general memory, as well as attention and executive function, among people with mild cognitive impairment, but it seems to take at least 8 weeks to work.
B vitamins including B-6, B-12, and folic acid, taken alone and/or in combination long-term, may help slow declines in memory and cognition in older adults with mild cognitive impairment.
Fish oil supplements high in DHA may help reduce further cognitive decline among people with MCI (but possibly only among those with low blood levels of omega-3 fatty acids prior to treatment and not those with higher IQ prior to treatment), although not all studies have found a benefit. There is also evidence that having adequate B vitamin status may be needed to benefit from fish oil supplementation.
Cocoa flavanols from chocolate, consumed in addition to fish oil, have not been shown to improve cognitive decline in people with MCI.
L-arginine supplementation may slightly improve cognitive function among some elderly individuals with mild cognitive impairment. Arginine can increase blood levels of nitric oxide, a compound that helps relax blood vessels and increase blood flow to various parts of the body. It may also help improve the function of mitochondria, the component of cells involved in energy production. Mitochondrial dysfunction has been linked with frailty and cognitive decline.
Medium chain triglycerides (MTC), occur naturally in coconut oil, can be converted by the liver into ketones, which, as discussed above, can be used by the brain as an alternative source of energy when glucose levels are low. Although one study in older adults with mild cognitive impairment found that a drink containing MCT oil significantly increased ketone uptake in the brain, participants had only slight improvements in episodic memory and executive function, but not in other measures of cognitive function.
Regular, long-term supplementation with a multivitamin may slightly slow declines in cognition and executive function in older adults with MCI, although it does not appear to reduce the risk of developing MCI.
Probiotics may modestly improve cognition in older adults with cognitive impairment.
Vitamin D supplementation may modestly improve cognition in older individuals with mild cognitive impairment who are vitamin D deficient, but does not appear to help in those who already have sufficient blood levels of vitamin D. Moderate dosing appears to be more beneficial than high dosing.
Supplementation with lion's mane may improve cognitive function in some people with mild cognitive impairment, although evidence is limited and the benefit, if any, appears to decline within 4 weeks of stopping treatment.
Although several small studies suggested that high doses of cocoa flavanols might moderately improve memory in older people with mild cognitive impairment, the largest study to-date found no benefit of cocoa flavanols for preventing or slowing the progression of mild cognitive impairment or dementia.
CoQ10 supplementation may improve the reactivity of blood vessels to the brain (which could potentially improve blood flow to the brain) in people with MCI, according to one study, but it did not lead to improvement in memory or cognitive function.
Taking grape seed extract for up to 6 months does not appear to improve cognitive function in older adults with mild cognitive impairment.
Plasmalogen supplements do not appear to improve cognitive function or memory in people with MCI.
For Alzheimer's Disease & Dementia
Acetyl-L-carnitine supplementation may have benefit in the early (mild) stages of Alzheimer’s disease.
Choline supplementation may improve cognition in people with mild to moderate Alzheimer's disease, but this benefit has only been found with certain forms of choline.
Fish oil supplementation may modestly improve cognitive performance in people with mild to moderate Alzheimer’s disease, but there may only be benefit in people with adequate B vitamin status.
Huperzine A has been shown to improve memory, thinking, and behavioral function in people with Alzheimer's disease, multi-infarct dementia, and senile dementia. It may also enhance the effects of medications such as may enhance the effects of prescription drugs donepezil (Aricept) or tacrine (Cognex).
Low-dose lithium may help prevent or slow the progression of dementia or Alzheimer's disease based on several small trials showing clinical or biological benefit, but not all research supports this neuroprotective effect.
Vitamin E supplementation, in high doses, may slightly improve memory and cognition in people with Alzheimer's disease. Taking lower doses of vitamin E doesn't seem to help people with normal cognitive function.
Possibly helpful, but no clinical studies:
Magnolia bark extract contains magnolol, honokiol, and other components that have been shown in laboratory studies to prevent the breakdown and increase levels of acetylcholine, a neurotransmitter that is essential for proper brain function, and to reduce the accumulation and neurotoxicity of amyloid proteins associated with Alzheimer's disease. Magnolia bark extracts and magnolol have been shown to lessen learning and memory impairments in mouse models of Alzheimer's disease, with the benefits of magnolol similar to that of donepezil, a prescription medication used for Alzheimer's disease (Lee, Biomol Ther (Seoul) 2012; Xian, Oxid Med Cell Longev 2020). However, it is not known if magnolia bark extract or its components are beneficial in preventing or treating Alzheimer's disease in humans, as no clinical trials have been reported.
Despite promising results from laboratory and animal studies, curcumin supplementation does not appear to improve memory or cognitive function among people with mild to moderate Alzheimer's disease, although it may help reduce agitation among people taking certain drugs for Alzheimer's disease.
Ginkgo biloba is often promoted to help treat dementias, including Alzheimer’s disease, but overall, there is no strong evidence from clinical trials showing a benefit.
A small clinical study among 24 people (average age 68) with mild cognitive impairment due to Alzheimer's disease showed that supplementing with 60 mg of the soy isoflavone genistein (Fisiogen by Zambon) twice daily for up to 12 months did not significantly improve most measures of cognitive function and did not significantly affect levels of beta-amyloid (a hallmark of Alzheimer's disease) in most regions of the brain, although there were slightly fewer amyloid deposits in the region of the brain that affects cognition and emotion for those treated with genistein compared to placebo (Viña, Alzheimers Res Ther 2022).
Melatonin levels in the blood and spinal fluid have been found to be lower among people with Alzheimer's compared to healthy older individuals. However, supplementing with melatonin doesn't seem to improve cognition or memory among people with Alzheimer's disease when evaluated using a reliable test for cognitive function.
Supplementing with a multivitamin does not appear to reduce the risk of developing Alzheimer’s disease or other forms of dementia, nor slow cognitive decline in people with these conditions.
Plasmalogen supplements do not appear to significantly improve cognitive function or memory in people with Alzheimer's disease.
Supplementation with lion's mane does not appear to improve most measure of cognitive function among people with Alzheimer's disease.
Cautions and Concerns with Supplements
The FDA has warned that many supplements promoted to treat Alzheimer's disease and dementia are marketed with unproven claims and are "selling false hope." The FDA has also advised consumers to avoid supplements promoted to prevent or treat traumatic brain injuries.
Vinpocetine, an ingredient in memory supplements such as Procera AVH and Alpha Brain, may cause fetal harm or miscarriage, and should not be taken by women who are pregnant or who could become pregnant. It can also inhibit blood platelets from forming clots and could dangerously interact with other blood-thinning supplements such as garlic, ginkgo and high dose vitamin E, and drugs such as aspirin, clopidogrel (Plavix), ticlopidine (Ticlid), or pentoxifylline (Trental) and Coumadin.
Also be aware that some supplements promoted for memory and cognition contain drugs not approved by the FDA and not permitted to be sold as dietary supplement ingredients. These drugs include Noopept (omberacetam) and its analogs, such as piracetam, aniracetam, oxiracetam or phenylpiracetam.
Centrophenoxine (also known as meclofenoxate) is a compound found in some supplements for memory and cognition as it has been shown to increase levels of choline and other neurotransmitters in animal studies, although clinical trials in people have generally been small and results have been mixed. It has been used in China, Japan and other countries (sold as Lucidril) to help treat dementia and brain trauma, but it has not been approved as drug in the U.S. An analysis of seven supplements labeled as containing centrophenoxine that were purchased online in the U.S. found that only one contained within 90 to 110% of its labeled amount, while the others contained much less (26% to 88% of the labeled amount). The products (which were not identified by name) provided 237 mg to 752 mg of centrophenoxine per day at their maximum recommended dosages (Cohen, Clin Toxicol (Phila) 2022). These amounts are in-line with those used in some clinical trials (250 mg up to 3,000 mg per day). There is little information about potential side effects of this drug, although insomnia, dizziness, restlessness, tremor, depression and nausea may occur at high doses. It is not recommended for people with a history of seizures, very high blood pressure, or Parkinson's disease.
Note that some experts have recommended that people at risk for Alzheimer's disease avoid copper-containing supplements due to possible contribution to cognitive decline. However, the evidence of this is limited and mixed. For details, see the Copper section of our Multivitamins Review.
Although an over-the-counter drug and not a supplement, some studies linked long-term use of proton pump inhibitors (PPIs) that reduce stomach acid, such as omeprazole, to increased risk of dementia (Gomm, JAMA Neurol 2016). However, larger studies found no link (Wu, Sci Rep 2021) or even a decreased risk of dementia among PPI users (Cooksey, PLoS One 2020). Furthermore, a large, clinical trial (which was sponsored by Bayer, a leading manufacturer of PPIs) among more than 17,000 people (average age 68) showed that taking 40 mg of pantoprazole (a PPI) daily for an average of about 3 years did not increase the risk of dementia compared to placebo (Moayyedi, Gastroenterology 2019).
Diet and Lifestyle Modifications for Memory:
Healthful diets have been associated with lower risk of dementia. However, clinical studies have yet to prove that these diets reduce dementia risk.
Diets providing higher intakes of certain antioxidant compounds have been associated with a decreased risk of Alzheimer's disease and other forms of dementia. In a study that followed over 2,500 people 50 years of age or older for 20 years, the risk of Alzheimer's and other dementias was reduced by 76% among those with higher intakes of anthocyanins (16 mg/day from foods such as blueberries, strawberries and red wine) and by 46% among those with higher intakes of flavonols (14 mg/day from foods such as tea, apples and pears) compared to those with the lowest intakes (4 mg/day and 6 mg/day, respectively) (Shishtar, Am J Clin Nutr 2020). These higher amounts are not difficult to obtain. For example, you can get 16 mg of anthocyanins from just ¼ cup of blueberries (Routray, Compr Rev Food Sci Food Saf 2011). However, a preliminary clinical trial among 10 men and women (average age 80) with mild cognitive impairment showed no change in blood biomarkers associated with risk of Alzheimer’s disease (amyloid-beta proteins and phosphorylated tau protein) compared to baseline after consuming 18 grams of freeze dried blueberry powder twice daily with meals (equivalent to about 1 ½ cups of blueberries per day) for 12 weeks (Doraiswamy, JAR Life 2023).
A small study among 37 healthy older men and women (ages 65 to 70) found that those who drank 12 grams of freeze-dried strawberry powder mixed in water with breakfast and dinner (24 grams of powder daily, equivalent to 2 cups of fresh strawberries) for three months had modest improvements in two of several measures of cognition (word recognition and spatial navigation) compared to placebo. There were no improvements in attention, task switching, verbal working memory, or mood. The researchers had also expected improvements in gait and balance, but they did not occur. The study was funded by the U.S. Department of Agriculture and California Strawberry Commission (Miller, Br J Nutr 2021).
A Mediterranean diet has also been associated with lower risk of dementia. A study in Italy among 1,902 adults 80 years or older showed that those who most closely followed a Mediterranean diet in the previous year were 34% less likely to have dementia than those who did not, even after adjusting for factors such as physical activity, alcohol intake and high blood pressure. Greater consumption of eggs, fruits and vegetables, carbohydrates, legumes (beans, lentils, peas, etc.) and greater food intake overall were also associated with a lower prevalence of dementia (Nicoli, Clin Nutr 2021).
A high-quality "MIND diet" (Mediterranean-DASH Diet Intervention for Neurodegenerative Delay) has also been associated with a decreased risk of Alzheimer dementia (Dhana, Neurology 2020). A 3-year clinical study among older, overweight adults with suboptimal diets found that those put on a MIND diet (that included 2.5 cups of blueberries, 5 oz of mixed nuts and 14 Tbsp of olive oil per week and involved cutting calories) and those put only on a calorie-reduced diet both experienced slight improvements in scores on cognitive tests and brain scans, and people in both groups lost similar amounts of weight (around 10 lbs. on average). Results were not statistically better, however, for those on the MIND diet (Barnes, N Engl J Med 2023). The MIND diet is based on favoring ten healthy food groups (leafy green vegetables, other vegetables, nuts, berries, beans, whole grains, fish, poultry, olive oil, and wine) over five unhealthy food groups (red meats, butter and stick margarine, cheese, pastries and sweets, fried food, and fast food).
Exercise and meditation:
Regular exercise may help improve some measures of cognitive function among adults with age-related cognitive decline or mild cognitive impairment, but it doesn’t seem to improve cognitive function among healthy older adults.
Regular exercise may help adults with mild cognitive impairment (MIC). A study in China among 282 men and women (average age 68) with type 2 diabetes and mild cognitive impairment found that those who engaged in supervised, regular exercise (either walking or tai chi, a series of slow, low-impact movements coordinated with breathing and mindfulness) for one hour, three times per week for five months, and were then encouraged to continue regular exercise for three additional months, showed that both exercise groups had modest, but significant improvement in cognition function compared to a control group who did not participate in regular exercise, although the greatest improvements were among those who performed tai chi. After eight months, participants in the tai chi group had an average increase of 3.29 points (on a scale of 0 to 30) on a cognitive assessment scale, compared to 2.32 points in the walking group, and 1.43 points in the control group. Those in the tai chi group also had a small, but statistically significant decrease in fasting blood sugar levels, but no improvement in HbA1C (a measure of blood sugar over weeks to months) compared to those in the walking group and control group (Chen, JAMA Netw Open 2023).
Exercise combined with cognitive training may also slightly improve cognition in older adults with mild cognitive impairment. A study among 170 men and women with mild cognitive impairment found that one hour of exercise (a combination of aerobic exercise and resistance training) in addition to 30 minutes of cognitive training (visual-motor tasks performed on an iPad), each performed three times weekly for six months, improved cognition (with an average decrease of 2.2 points on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog 13), which ranges from 0 to 84 points with lower scores indicating better cognitive function), while there was no improvement and/or cognitive decline among those who participated in exercise-only, or cognitive training only. Although this improvement was statistically significant compared to the exercise-only and cognitive training-only groups, it’s not clear if the improvements were clinically meaningful. Some participants in the trial also took high-dose vitamin D (10,000 IU three times weekly), but most of the participants had sufficient blood levels of vitamin D at the start of the study, and supplementation did not affect outcomes (Montero-Odasso, Alzheimers Dement 2022).
While some research suggested that, in healthy older adults, aerobic exercise may increase volume in brain regions associated with age-related cognitive decline (Colcombe, J Gerontol A Biol Sci Med Sci 2006), a study among 475 generally healthy older men and women (average age 71) with self-reported memory and cognition concerns found that participating in regular daily exercise (aerobic exercise, resistance training, and functional exercises) 5 hours per week, alone or in addition to one hour per day of mindfulness meditation (to reduce stress and increase focus and awareness), for up to 18 months, did not improve episodic memory or executive function, or reduce age-related loss of hippocampal volume, compared to a control group who received basic health education but did not participate in the exercise program or practice mindfulness meditation. Similarly, mindfulness meditation alone, without exercise, did not have a benefit compared to the control (Lenze, JAMA 2022).
Preliminary clinical research suggests that taking short naps in the afternoon may modestly improve cognitive function in older people with mild cognitive impairment, although higher quality studies are needed to confirm. A study in Thailand among 38 adults (average age 66) with mild cognitive impairment who were not regular nappers showed that taking 20-minute naps in the early afternoon three days per week for 8 weeks slightly improved cognitive function by 3.47 points (on a scale of 0 to 30) compared to baseline, although average scores remained within the diagnostic range for MCI. Quality of life also slightly improved by 3.70 points (on a scale of 13 to 52), and overall quality of sleep improved among those with or without poor sleep quality at baseline (Pengsuwankasem, Neurosci Lett 2023).
A 6-month study in China among 66 people (average age 83) with mild Alzheimer's disease showed that those who followed oral health intervention strategies while also receiving routine care for Alzheimer’s disease showed only slight declines (worsening) on cognitive tests and a slight improvement on a behavioral test, and these improvements were statistically significant compared to a group that received routine care without the oral health intervention and had greater declines in cognition function and worsening of scores on the behavioral test. In addition to regular brushing with toothpaste, the intervention included visits with a facilitator 3 times weekly to support oral self-care; self-swabbing inside the mouth (including the teeth, gums and tongue) 3 times weekly with 0.2% chlorhexidine gluconate (an antibiotic) followed by warm water rinsing; and participating in educational courses on topics including coping strategies for cognitive impairment and the benefits of exercise. Unfortunately, due to the study design, it was not possible to assess the impact of the oral care separately from that of the educational courses (Chen, Geriatr Nurs 2022). Although the exact mechanism by which oral health may affect cognitive decline is unknown, there is speculation that bacteria in the mouth that contribute to gum disease may cross the blood-brain barrier and contribute to Alzheimer's disease progression (Borsa, Int J Environ Res Public Health 2021).
In addition the results of its expert testing, ConsumerLab uses only high-quality, evidence based, information sources. These sources include peer-reviewed studies and information from agencies such as the FDA and USDA, and the National Academy of Medicine. On evolving topics, studies from pre-print journals may be sourced. All of our content is reviewed by medical doctors and doctoral-level experts in pharmacology, toxicology, and chemistry. We continually update and medically review our information to keep our content trustworthy, accurate, and reliable. The following sources are referenced in this article:
- Barnes, N Engl J Med 2023
- Borsa, Int J Environ Res Public Health 2021
- Chen, Geriatr Nurs 2022
- Chen, JAMA Netw Open 2023
- Cohen, Clin Toxicol (Phila
- Colcombe, J Gerontol A Biol Sci Med Sci 2006
- Cooksey, PLoS One 2020
- Dhana, Neurology 2020
- Doraiswamy, JAR Life 2023
- Gomm, JAMA Neurol 2016
- Hersant, CNS Drugs 2023
- Lee, Biomol Ther (Seoul
- Lenze, JAMA 2022
- Miller, Br J Nutr 2021
- Moayyedi, Gastroenterology 2019
- Montero-Odasso, Alzheimers Dement 2022
- Nicoli, Clin Nutr 2021
- Nouchi, Front Aging Neurosci 2022
- Nowotarski, Expert Rev Mol Med 2013
- Pengsuwankasem, Neurosci Lett 2023
- Routray, Compr Rev Food Sci Food Saf 2011
- Schwarz, JAMA Netw Open 2022
- Senekowitsch, Nutrients 2023
- Shishtar, Am J Clin Nutr 2020
- Viña, Alzheimers Res Ther 2022
- Wu, Sci Rep 2021